For the Quarter Ending September 2025
APAC
• In China, the Salcaprozate Sodium Price Index rose quarter-over-quarter in Q3 2025, driven by firming feedstock costs.
• Salcaprozate Sodium production costs increased in Q3 2025 due to tightened salicylic acid supply from environmental inspections.
• Demand for Salcaprozate Sodium strengthened in Q3 2025, supported by robust pharmaceutical market growth and accelerating clinical trials.
• China's industrial production grew by 6.5% in September 2025, indicating sustained demand for chemical inputs.
• Retail sales increased by 3.0% in September 2025, bolstering consumer spending on healthcare products.
• The Manufacturing Index was contracting in September 2025, suggesting some slowdown in overall industrial activity.
• Deflationary CPI at -0.3% and PPI at -2.3% in September 2025 exerted downward pressure on end-product pricing.
• Salcaprozate Sodium's price forecast suggests continued upward pressure from feedstock costs and robust pharmaceutical demand.
Why did the price of Salcaprozate Sodium change in September 2025 in APAC?
• Salicylic acid feedstock costs firmed in Q3 2025, and supply tightened due to environmental inspections in China.
• Robust pharmaceutical market growth and accelerating clinical trials in China boosted Salcaprozate Sodium demand.
• Industrial production increased by 6.5% in September 2025, supporting demand despite a contracting Manufacturing Index.
Europe
• In Germany, the Salcaprozate Sodium Price Index rose quarter-over-quarter in Q3 2025, driven by strengthening pharmaceutical demand.
• Production costs for Salcaprozate Sodium rose from elevated natural gas and industrial electricity prices in Q3 2025.
• Demand for Salcaprozate Sodium strengthened in Q3 2025, supported by sustained growth in oral pharmaceutical formulations.
• Germany's Manufacturing Index contracted in Q3 2025, indicating a slowdown in overall industrial activity.
• Industrial production declined by 1.0% in September 2025, reflecting weaker demand from key industrial consumers.
• Producer prices for industrial products decreased by 1.7% in September 2025, primarily due to lower energy prices.
• The Consumer Price Index increased by 2.4% in September 2025, suggesting rising overall production costs for manufacturers.
• Stable retail sales (0.2% in September 2025) and unemployment (6.3%) provided a neutral backdrop for consumer spending.
• Factors influencing Salcaprozate Sodium price outlook include robust pharmaceutical demand and persistent high energy costs.
Why did the price of Salcaprozate Sodium change in September 2025 in Europe?
• Strengthening German pharmaceutical demand (sector signal) supported Salcaprozate Sodium prices.
• Elevated natural gas and industrial electricity prices increased production costs.
• Overall industrial production declined 1.0% in September 2025, moderating demand for chemical inputs.
North America
• In United States, the Salcaprozate Sodium Price Index rose quarter-over-quarter in Q3 2025, driven by increasing production costs.
• Salcaprozate Sodium production costs faced upward pressure from a 2.6% year-over-year Producer Price Index increase in August 2025.
• Overall inflation, with Consumer Price Index up 3.0% year-over-year in September 2025, raised raw material and labor expenses.
• Salcaprozate Sodium demand outlook was supported by strengthened pharmaceutical sector activity in Q3 2025.
• Rising US natural gas prices and wholesale electricity costs in Q3 2025 increased energy inputs for production.
• North American caustic soda feedstock costs experienced a quarterly decrease during Q3 2025, partially mitigating overall cost trends.
• A low 0.1% year-over-year industrial production growth in September 2025 indicated sluggish broader manufacturing activity.
• Strong retail sales, up 5.42% year-over-year in September 2025, indirectly bolstered pharmaceutical product demand.
Why did the price of Salcaprozate Sodium change in September 2025 in North America?
• Increased production costs, driven by a 2.6% year-over-year Producer Price Index rise in August 2025, impacted Salcaprozate Sodium.
• Strengthened pharmaceutical sector demand in Q3 2025, with increased regulatory approvals, supported Salcaprozate Sodium prices.
• Rising US natural gas prices and wholesale electricity costs in Q3 2025 contributed to higher manufacturing expenses.
